1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. SYNLAB AG
  6. News
  7. Summary
    SYAB   DE000A2TSL71

SYNLAB AG

(SYAB)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 05/19 03:59:52 pm
16.87 EUR   0.00%
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SYNLAB : Raised to Buy by Barclays

01/17/2022 | 02:19am EDT

Barclays's analyst Hassan Al-Wakeel raises his rating from Neutral to Buy. The target price is increased from EUR 21 to EUR 25.


© MarketScreener with dpa-AFX Analyser 2022
All news about SYNLAB AG
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12TRANSCRIPT : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
CI
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
05/12SYNLAB : Jefferies reaffirms its Buy rating
MD
05/12SYNLAB reports a strong start to the fiscal year 2022
EQ
05/12SYNLAB AG Revises Earnings Guidance for 2022
CI
05/12SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/10SYNLAB AG : SYNLAB Medical Congress: making healthcare future-proof with advanced diagnost..
EQ
More news
Analyst Recommendations on SYNLAB AG
More recommendations
Financials
Sales 2022 3 163 M 3 349 M 3 349 M
Net income 2022 309 M 328 M 328 M
Net Debt 2022 1 508 M 1 597 M 1 597 M
P/E ratio 2022 11,6x
Yield 2022 1,84%
Capitalization 3 676 M 3 892 M 3 892 M
EV / Sales 2022 1,64x
EV / Sales 2023 1,74x
Nbr of Employees 25 750
Free-Float 75,7%
Chart SYNLAB AG
Duration : Period :
SYNLAB AG Technical Analysis Chart | SYAB | DE000A2TSL71 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 16,54 €
Average target price 22,49 €
Spread / Average Target 36,0%
EPS Revisions
Managers and Directors
Mathieu Olivier Floreani Chairman-Management Board & CEO
Sami Badarani Chief Financial Officer
David Raymond Ebsworth Chairman-Supervisory Board
Santiago Valor Garcia Chief Medical Officer
Henrik Andreasen Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
SYNLAB AG-27.91%3 934
SONIC HEALTHCARE LIMITED-22.39%12 020
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-26.91%5 716
DR. LAL PATHLABS LIMITED-49.84%2 183
DIAGNOSTICOS DA AMÉRICA S.A.-42.92%2 156
HEALIUS LIMITED-20.45%1 689